Jay A. Fishman Ltd’s Kythera Biopharmaceuticals KYTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
– Sell
-34,500
Closed -$2.6M – 98
2015
Q2
$2.6M Hold
34,500
– – 0.54% 36
2015
Q1
$1.73M Buy
34,500
+8,000
+30% +$336K 0.36% 45
2014
Q4
$919K Hold
26,500
– – 0.2% 61
2014
Q3
$868K Buy
26,500
+700
+3% +$24.7K 0.19% 60
2014
Q2
$990K Buy
25,800
+6,300
+32% +$220K 0.21% 60
2014
Q1
$775K Hold
19,500
– – 0.17% 64
2013
Q4
$728K Hold
19,500
– – 0.16% 66
2013
Q3
$889K Hold
19,500
– – 0.22% 63
2013
Q2
$527K Buy
+19,500
New +$446K 0.14% 70

Other funds holding KYTH

Jay A. Fishman Ltd's KYTH Position: Q3 2015 in Review

Jay A. Fishman Ltd sold out of Kythera Biopharmaceuticals (KYTH) in Q3 2015, closing a stake of 34,500 shares — an estimated $2.6M sold.

Jay A. Fishman Ltd first reported a position in KYTH in Q2 2013 and held it in 9 quarters. The position peaked at $2.6M in Q2 2015. 143 funds tracked by Wall St. Rank hold KYTH as of Q3 2015.

  • Jay A. Fishman Ltd reported no remaining Kythera Biopharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Jay A. Fishman Ltd sold 34,500 Kythera Biopharmaceuticals shares in Q3 2015, an estimated $2.6M.
  • Jay A. Fishman Ltd first reported a position in Kythera Biopharmaceuticals in Q2 2013 and held it in 9 quarters.
  • Jay A. Fishman Ltd's Kythera Biopharmaceuticals position peaked at $2.6M in Q2 2015.
  • 143 funds tracked by Wall St. Rank held Kythera Biopharmaceuticals as of Q3 2015.

Based on Jay A. Fishman Ltd's 13F filing for Q3 2015, filed 2 Nov 2015.